Table 4 Clinical progress of study population
Adverse event | Frequency (%) |
|---|---|
Local recurrence  | 68(26.2) |
Distant metastases  | 74(28.5) |
All cases of recurrence  | 142(54.6) |
Total case files included | 260(100) |
Sites of recurrence | |
 Chest wall | 68(26.2) |
 Brain | 14(5.4) |
 Bone | 24(9.2) |
 Liver | 7(2.7) |
 Lung | 22(8.5) |
 Lymph nodes | 18(6.9) |
 Bone and brain | 2(0.8) |
 Bone and lung | 5(1.9) |
 Liver and lung | 1(0.4) |
 Brain and lung | 3(1.2) |
 Brain and liver | 1(0.4) |
Sequelae | |
 1. Lymphatic: lymphoedema of arm | 17(6.5) |
 2. Pulmonary: lung fibrosis | 4(1.5) |
 3. Neurologic: plexopathy | 1(0.4) |
 4. Dermatologic: skin fibrosis | 1(0.4) |
  radiodermatitis | 1(0.4) |
 5. Vascular: telangiectasia | 1(0.4) |
 6. Bone: rib fracture | 1(0.4) |
All cases with sequelae | 26(10.8) |